Realizing “Pharma Foods” through the Fusion of Pharmaceuticals and Food
First written in FY2016-Q3. 22 of 27 entries say "Restated". Latest entry: 2026-09-11.
The whole theme swung hardest in 2024: 1 of 6 companies on the "Worse" side.
1 other company's latest entry also says "Restated".
- 2026-09-11RestatedRevision of earnings forecasts
「Against this social backdrop, our group launched the New Value Creation 1K Project under Medium-Term Management Plan 2026.」
The company reaffirmed its aim of becoming a leading healthcare company and continuing its medium-term management plan. - FY2024ReframedAnnual report
「The Group aims to realize a sustainable, healthy and happy society for people and has established the following MVV: Mission: Contribute through research into medicine and food. Vision: Become a leading healthcare company. Values: Integrity and a willingness to take on challenges.」
The Company has organized its overall policy as an MVV comprising the mission “Contribute through research into medicine and food,” the vision “Become a leading healthcare company” and its Values. - FY2024-Q2ReframedAnnual report
「The Group has adopted the mission “Contribute through research into medicine and food” and aims to realize a sustainable, healthy and happy society for people.」
The Company has simplified the expression of its mission from “Advance research into medicine and food to contribute to people” to “Contribute through research into medicine and food.” - FY2024-Q1RestatedAnnual report
「The Group has adopted the mission “Advance research into medicine and food to contribute to people” and aims to realize a sustainable, healthy and happy society for people. To this end, it develops foods, cosmetics and pharmaceuticals based on scientific evidence and broadly provides society with its proprietary research findings and products through its three businesses: BtoB, BtoC and Biomedical.」
The Company continues its mission of “advancing research into medicine and food to contribute to people,” its development of foods, cosmetics and pharmaceuticals based on scientific evidence, and their provision through three businesses. - FY2023ReframedAnnual report
「The Group has adopted the mission “Advance research into medicine and food to contribute to people” and aims to realize a sustainable, healthy and happy society for people.」
The Company has reorganized its basic overall policy from the former expression “integrating pharmaceuticals and food” into the mission “Advance research into medicine and food to contribute to people.” - FY2023-Q2RestatedAnnual report
「The Group has adopted the sustainability vision “Valuable abundance and valuable health in the age of 100-year lifespans” and aims to realize a sustainable, healthy and happy society for people. To this end, it develops foods, cosmetics and pharmaceuticals based on scientific evidence and broadly provides society with its proprietary research findings and products through its three businesses: BtoB, BtoC and Biomedical.」
The Company continues to uphold its sustainability vision and reaffirms its development of foods, cosmetics and pharmaceuticals and their provision through three businesses. - FY2023-Q1RestatedAnnual report
「The Group has adopted the sustainability vision “Valuable abundance and valuable health in the age of 100-year lifespans” and aims to realize a sustainable, healthy and happy society for people. To this end, it develops foods, cosmetics and pharmaceuticals based on scientific evidence and broadly provides society with its proprietary research findings and products through its three businesses: BtoB, BtoC and Biomedical.」
The Company continues to uphold its vision of health and prosperity and its research and development and provision of foods, cosmetics and pharmaceuticals through three businesses. - FY2022RestatedAnnual report
「The Group has adopted the sustainability vision “Valuable abundance and valuable health in the age of 100-year lifespans” and aims to realize a sustainable, healthy and happy society for people.」
The Company continues to uphold its sustainability vision and its overall direction of providing foods, cosmetics and pharmaceuticals through three businesses. - FY2022-Q3RestatedAnnual report
「The Group has adopted the sustainability vision “Valuable abundance and valuable health in the age of 100-year lifespans” and aims to realize a sustainable and prosperous society by contributing to people’s lasting happiness through health in today’s longevity-focused society. To this end, it broadly provides society with its proprietary research findings and products based on scientific evidence, including foods, cosmetics and pharmaceuticals, through its three businesses: BtoB, BtoC and Biomedical.」
This reaffirms the Company-wide direction based on health, pharmaceuticals and food, and the provision of products and research findings through its three businesses. - FY2022-Q2RestatedAnnual report
「To realize “Pharma Foods,” the integration of “Pharmaceuticals” and “Foods,” the Group uses the “Bio Business Triangle” concept and operates three main businesses: “Functional Ingredients (Bio seeds),” “Biomedical (Bio medical)” and “Direct-to-Consumer Sales (Bio value).”」
The Company continues its policy of integrating pharmaceuticals and food, using the “Bio Business Triangle” and its three businesses as its main businesses. - FY2022-Q1RestatedAnnual report
「To realize “Pharma Foods,” the integration of “Pharmaceuticals” and “Foods,” the Group uses the “Bio Business Triangle” concept and operates three main businesses: “Functional Ingredients (Bio seeds),” “Biomedical (Bio medical)” and “Direct-to-Consumer Sales (Bio value).”」
The Company continues its overall policy of integrating pharmaceuticals and food, using the Bio Business Triangle and its three businesses as its main businesses. - FY2021RestatedAnnual report
「The Group aims to realize “Pharmafoods,” the integration of “Pharmaceuticals” and “Foods,” and develops functional ingredients that help maintain health and improve quality of life.」
The Group continues to pursue its basic policy of integrating pharmaceuticals and food, with the development of functional ingredients that help maintain health and improve quality of life as a core business focus. - FY2021-Q3RestatedAnnual report
「To realize “Pharma Foods,” the integration of “Pharmaceuticals” and “Foods,” the Group uses the “Bio Business Triangle” concept and operates three main businesses: “Functional Ingredients (Bio seeds),” “Biomedical (Bio medical)” and “Direct-to-Consumer Sales (Bio value).”」
The Company continues to uphold the integration of pharmaceuticals and food and the three-business structure under the Bio Business Triangle. - FY2021-Q2RestatedAnnual report
「To realize “Pharma Foods,” the integration of “Pharmaceuticals” and “Foods,” the Group uses the “Bio Business Triangle” concept and operates three main businesses: “Functional Ingredients (Bio seeds),” “Biomedical (Bio medical)” and “Direct-to-Consumer Sales (Bio value).”」
The Company continues to uphold the integration of pharmaceuticals and food and the three-business structure under the Bio Business Triangle. - FY2021-Q1RestatedAnnual report
「To realize “Pharma Foods,” the integration of “Pharmaceuticals” and “Foods,” the Group uses the “Bio Business Triangle” concept and operates three main businesses: “Functional Ingredients (Bio seeds),” “Biomedical (Bio medical)” and “Direct-to-Consumer Sales (Bio value).”」
The Company continues its overall policy of pursuing the integration of pharmaceuticals and food and operating the three Bio Business Triangle businesses as its main businesses. - FY2020-Q1RestatedAnnual report
「To realize “Pharma Foods,” the integration of “Pharmaceuticals” and “Foods,” the Group uses the “Bio Business Triangle” concept and actively develops its three main businesses: “Biomedical (Bio medical),” “Functional Ingredients (Bio seeds)” and “Direct-to-Consumer Sales (Bio value).”」
The Company continues to uphold the integration of pharmaceuticals and food and the three-business structure under the Bio Business Triangle as its basic overall policy. - FY2019RestatedAnnual report
「The Group aims to realize “Pharmafoods,” the integration of “Pharmaceuticals” and “Foods,” and develops functional ingredients that help maintain health and improve quality of life.」
The Group continues to pursue its basic policy of integrating pharmaceuticals and food and explicitly identifies the development of functional ingredients as the means of doing so. - FY2019-Q3RestatedAnnual report
「To realize “Pharma Foods,” the integration of “Pharmaceuticals” and “Foods,” the Group uses the “Bio Business Triangle” concept and operates three main businesses: “Biomedical (Bio medical),” “Functional Ingredients (Bio seeds)” and “Direct-to-Consumer Sales (Bio value).”」
The Company continues to uphold the integration of pharmaceuticals and food and the three-business structure under the Bio Business Triangle. - FY2019-Q2RestatedAnnual report
「To realize “Pharma Foods,” the integration of “Pharmaceuticals” and “Foods,” the Group uses the “Bio Business Triangle” concept and operates three main businesses: “Biomedical (Bio medical),” “Functional Ingredients (Bio seeds)” and “Direct-to-Consumer Sales (Bio value).”」
The Company continues to uphold the integration of pharmaceuticals and food and the three-business structure under the Bio Business Triangle. - FY2019-Q1ReframedAnnual report
「To realize “Pharma Foods,” the integration of “Pharmaceuticals” and “Foods,” the Group uses the “Bio Business Triangle” concept and operates three main businesses: “Functional Ingredients (Bio seeds),” “Biomedical (Bio medical)” and “Direct-to-Consumer Sales (Bio value).”」
While maintaining its existing direction of integrating pharmaceuticals and food, the Company explicitly identifies a business structure centered on three main businesses under the “Bio Business Triangle” concept. - FY2018-Q3RestatedAnnual report
「Against this backdrop, the Group has expanded its business with the aim of realizing “Pharma Foods,” the integration of “Pharmaceuticals” and “Foods,” by developing food ingredients, health foods and cosmetics with clearly defined functions that help maintain health and improve quality of life, as well as creating pharmaceuticals.」
The Company continues to pursue its overall policy of developing food ingredients, health foods and cosmetics and creating pharmaceuticals in order to realize the integration of pharmaceuticals and food. - FY2018-Q2RestatedAnnual report
「Against this backdrop, the Group has expanded its business with the aim of realizing “Pharma Foods,” the integration of “Pharmaceuticals” and “Foods,” by developing food ingredients, health foods and cosmetics with clearly defined functions that help maintain health and improve quality of life, as well as creating pharmaceuticals.」
This reaffirms the direction of realizing the integration of pharmaceuticals and food and specifically identifies the business areas of developing food ingredients, health foods and cosmetics, and creating pharmaceuticals. - FY2018-Q1RestatedAnnual report
「Against this backdrop, we have actively expanded our business with the aim of integrating “Pharmaceuticals” and “Foods” to realize “Pharma Foods.”」
The Company continues to uphold its overall direction of pursuing the integration of pharmaceuticals and food. - FY2017-Q3RestatedAnnual report
「Against this backdrop, we have actively expanded our business with the aim of integrating “Pharmaceuticals” and “Foods” to realize “Pharma Foods.”」
The Company continues to pursue its overall direction of integrating pharmaceuticals and food. - FY2017-Q2RestatedAnnual report
「Against this backdrop, we have actively expanded our business with the aim of integrating “Pharmaceuticals” and “Foods” to realize “Pharma Foods.”」
The Company continues to uphold its overall direction of pursuing the integration of pharmaceuticals and food. - FY2017-Q1RestatedAnnual report
「Against this backdrop, we have actively expanded our business with the aim of integrating “Pharmaceuticals” and “Foods” to realize “Pharma Foods.”」
The Company continues to uphold its overall direction of pursuing the integration of pharmaceuticals and food. - FY2016-Q3First statedAnnual report
「Against this backdrop, we have actively expanded our business with the aim of integrating “Pharmaceuticals” and “Foods” to realize “Pharma Foods.”」
This sets out the Company-wide direction of pursuing a business that integrates pharmaceuticals and food.